Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

JOURNAL ARTICLE published April 2016 in The Lancet

Authors: Roy S Herbst | Paul Baas | Dong-Wan Kim | Enriqueta Felip | José L Pérez-Gracia | Ji-Youn Han | Julian Molina | Joo-Hang Kim | Catherine Dubos Arvis | Myung-Ju Ahn | Margarita Majem | Mary J Fidler | Gilberto de Castro | Marcelo Garrido | Gregory M Lubiniecki | Yue Shentu | Ellie Im | Marisa Dolled-Filhart | Edward B Garon